Sign In
Get Clay Free →

Suggestions

    Peter Whitfeld

    Company Secretary at AdvanCell Isotopes Pty Ltd

    Peter Whitfeld is the Company Secretary at AdvanCell Isotopes Pty Ltd, a radiopharmaceutical company focused on developing Targeted Alpha Therapies for cancer treatment. He has over 30 years of experience in biotechnology research and development, as well as intellectual property management.12 Prior to his role at AdvanCell, Dr. Whitfeld held senior positions at the Garvan Institute of Medical Research, including Senior Contracts Manager in the Legal Office and roles in the Partnerships and Business Development Office. He also worked at G2 Therapies, where he managed the C5aR program and led the team responsible for humanizing therapeutic antibodies.2 Dr. Whitfeld holds a PhD from the Australian National University, Research School of Biological Sciences.2 His LinkedIn profile is available under the username peter-whitfeld-03aa3152.3

    Highlights

    Jan 1 · advancell.com.au
    Company - AdvanCell
    Company - AdvanCell
    Dec 27 · sec.gov
    FORM D - SEC.gov
    Aug 23 · businesswire.com
    AdvanCell Closes A$18M Series B Funding Led by Morningside

    Related Questions

    What are Peter Whitfeld's key achievements in biotechnology research?
    How has Peter Whitfeld contributed to the development of Targeted Alpha Therapy at AdvanCell?
    What is Peter Whitfeld's educational background?
    How long has Peter Whitfeld been with AdvanCell Isotopes Pty Ltd?
    What other roles has Peter Whitfeld held in his career?
    Peter Whitfeld
    Peter Whitfeld, photo 1
    Peter Whitfeld, photo 2
    Add to my network

    Location

    Sydney, New South Wales, Australia